Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart G Baker

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
BMC Cancer|August 9, 2007
Paradoxes in carcinogenesis: new opportunities for research directionsStuart G Baker, Barnett S Kramer
Statistical Methods in Medical Research|September 24, 2005
Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysisStuart G Baker, Barnett S Kramer
Journal of the National Cancer Institute|November 4, 2010
Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk predictionStuart G Baker, Daniel J Sargent
Journal of Medical Screening|February 3, 2026
Adjusting for non-compliance and contamination with a more plausible assumptionStuart G Baker, Karen S Lindeman
Cancers|May 14, 2025
The Role of the Extracellular Matrix in Cancer PreventionStuart G Baker, Edward R Sauter
Statistics in Medicine|September 5, 2002
Evaluating serial observations of precancerous lesions for further study as a trigger for early interventionStuart G Baker, Melvyn S Tockman
BMC Medical Research Methodology|September 10, 2003
A perfect correlate does not a surrogate makeStuart G Baker, Barnett S Kramer
BMC Bioinformatics|September 9, 2006
Identifying genes that contribute most to good classification in microarraysStuart G Baker, Barnett S Kramer
Clinical Trials (London, England)|November 12, 2014
Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themesStuart G Baker, Barnett S Kramer
Annals of Internal Medicine|December 2, 2014
Instrumental variable analyses for observational comparative effectiveness research: the paired availability designStuart G Baker, Karen S Lindeman
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
BMC Cancer|August 9, 2007
Paradoxes in carcinogenesis: new opportunities for research directionsStuart G Baker, Barnett S Kramer
Statistical Methods in Medical Research|September 24, 2005
Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysisStuart G Baker, Barnett S Kramer
Journal of the National Cancer Institute|November 4, 2010
Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk predictionStuart G Baker, Daniel J Sargent
Journal of Medical Screening|February 3, 2026
Adjusting for non-compliance and contamination with a more plausible assumptionStuart G Baker, Karen S Lindeman
Cancers|May 14, 2025
The Role of the Extracellular Matrix in Cancer PreventionStuart G Baker, Edward R Sauter
Statistics in Medicine|September 5, 2002
Evaluating serial observations of precancerous lesions for further study as a trigger for early interventionStuart G Baker, Melvyn S Tockman
BMC Medical Research Methodology|September 10, 2003
A perfect correlate does not a surrogate makeStuart G Baker, Barnett S Kramer
BMC Bioinformatics|September 9, 2006
Identifying genes that contribute most to good classification in microarraysStuart G Baker, Barnett S Kramer
Clinical Trials (London, England)|November 12, 2014
Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themesStuart G Baker, Barnett S Kramer
Annals of Internal Medicine|December 2, 2014
Instrumental variable analyses for observational comparative effectiveness research: the paired availability designStuart G Baker, Karen S Lindeman
Pageof 12